Repligen (RGEN) Depreciation & Amortization (CF) (2010 - 2026)
Repligen's (RGEN) quarterly Depreciation & Amortization (CF) came in at $19.1 million in Q2 2026, down 5.07% year-over-year from $20.1 million in Q2 2025, and down 3.54% quarter-over-quarter from $19.8 million in Q1 2026.
Analysis
Repligen (RGEN) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $19.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 5.07% year-over-year to $19.1 million in Q2 2026; TTM through Jun 2026 was $78.8 million, a 5.65% increase from a year earlier, with the FY2025 full-year figure at $78.7 million, up 13.02% from the prior year.
- Depreciation & Amortization (CF) was $19.1 million for Q2 2026 at Repligen, down from $19.8 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $20.1 million in Q2 2025 and troughed at $11.8 million in Q1 2022.
- A 5-year average of $17.0 million and a median of $17.3 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) surged 56.42% in 2023 and slipped 12.11% in 2024, its largest moves.
- Over 5 years, Depreciation & Amortization (CF) stood at $14.4 million in 2022, then advanced by 20.03% to $17.3 million in 2023, then gained by 6.41% to $18.4 million in 2024, then grew by 8.62% to $20.0 million in 2025, then slipped by 4.46% to $19.1 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $19.1 million (Q2 2026), $19.8 million (Q1 2026), and $20.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | - |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 66.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | - |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 102.04 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 24.14 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 19.06 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 9.66 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 58.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.06 Mn |
| Mar 31, 2026 | 19.76 Mn |
| Dec 31, 2025 | 19.95 Mn |
| Sep 30, 2025 | 20.01 Mn |
| Jun 30, 2025 | 20.08 Mn |
| Mar 31, 2025 | 18.70 Mn |
| Dec 31, 2024 | 18.37 Mn |
| Sep 30, 2024 | 17.42 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Mar 31, 2024 | 16.91 Mn |
| Dec 31, 2023 | 17.26 Mn |
| Sep 30, 2023 | 19.82 Mn |
| Jun 30, 2023 | 16.10 Mn |
| Mar 31, 2023 | 15.37 Mn |
| Dec 31, 2022 | 14.38 Mn |
| Sep 30, 2022 | 12.67 Mn |
| Jun 30, 2022 | 12.10 Mn |
| Mar 31, 2022 | 11.83 Mn |
| Dec 31, 2021 | 11.02 Mn |
| Sep 30, 2021 | 10.01 Mn |